TuHURA Biosciences, Inc./NV Net Income Loss

• TuHURA Biosciences, Inc./NV showed a decrease of -38.6% in Net Income Loss from 2024 to 2025.
• This data is from TuHURA Biosciences, Inc./NV's annual report (Form 10-K), filed with the SEC on March 31, 2026.
• XBRL data for this metric is available from 2011 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 17 years of available data (2011 to 2025), TuHURA Biosciences, Inc./NV's Net Income Loss has declined by 2,154.4%.
• Historical annual values: Fiscal year 2025: -$30.05 million | Fiscal year 2024: -$21.68 million | Fiscal year 2024: -$8.32 million | Fiscal year 2023: -$29.32 million | Fiscal year 2023: -$14.65 million | Fiscal year 2022: -$22.66 million | Fiscal year 2021: -$38.30 million | Fiscal year 2020: -$9.13 million | Fiscal year 2019: -$8.05 million | Fiscal year 2018: $11.14 million | Fiscal year 2017: $8.08 million | Fiscal year 2016: $8.86 million | Fiscal year 2015: -$4.80 million | Fiscal year 2014: $3.13 million | Fiscal year 2013: -$8.29 million | Fiscal year 2012: -$2.40 million | Fiscal year 2011: -$1.33 million.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026